Latest Articles
Masterclass on ‘Missed Periods’ - Deccan Chronicle
Masterclass on ‘Missed Periods’ Deccan Chronicle
Published: Oct. 7, 2026, 1:50 p.m.
New Endometriosis Drug Shows Promise in Mouse Study - tovima.com
New Endometriosis Drug Shows Promise in Mouse Study tovima.com
Published: Oct. 7, 2026, 3:03 a.m.
Former Miss Universe Philippines Celeste Cortesi gets candid about her pregnancy journey. She is nine months pregnant with her first child, Sergio. Check the comments section for the full story. - facebook.com
Former Miss Universe Philippines Celeste Cortesi gets candid about her pregnancy journey. She is nine months pregnant with her first child, Sergio. Check the comments section for the full story. …
Published: Oct. 2, 2026, 12:30 p.m.
Former Miss Ireland reveals excruciating pain and hair loss as she slams dismissal - irishstar.com
Former Miss Ireland reveals excruciating pain and hair loss as she slams dismissal irishstar.com
Published: Oct. 2, 2026, 12:16 p.m.
Former Miss Ireland reveals excruciating pain and hair loss as she slams dismissal - Irish Star
Former Miss Ireland reveals excruciating pain and hair loss as she slams dismissal Irish Star
Published: Oct. 2, 2026, 12:16 p.m.
Endometriosis: Repurposed Anti-Parasite Drug Shows Promise In Mouse Study - Health and Me
Endometriosis: Repurposed Anti-Parasite Drug Shows Promise In Mouse Study Health and Me
Published: Oct. 2, 2026, 6:21 a.m.
Former Miss Ireland tells of excruciating pain ordeal, hair loss struggles - and collapse - irishmirror.ie
Former Miss Ireland tells of excruciating pain ordeal, hair loss struggles - and collapse irishmirror.ie
Published: Oct. 2, 2026, 4:21 a.m.
Former Miss Ireland tells of excruciating pain ordeal, hair loss struggles - and collapse - Irish Mirror
Former Miss Ireland tells of excruciating pain ordeal, hair loss struggles - and collapse Irish Mirror
Published: Oct. 2, 2026, 4:21 a.m.
Opiranserin (VVZ-149): what's new in analgesics.
Opiranserin (VVZ-149) is a novel non-opioid, non-steroidal intravenous analgesic with triple antagonistic activity at glycine transporter 2 (GlyT2), purine 2 receptor 3 (P2X3), and serotonin receptor (5-HT2A). Its half-maximal inhibitory …
Published: Oct. 2, 2026, midnight
The 'missed disease' that affects 190 million: endometriosis drug shows early promise.
Published: Oct. 1, 2026, midnight
Link copied to clipboard!